Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03 janv. 2025 09h01 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced that the Company entered into a...
Reliance Global Group Appoints David Lazar to Board of Directors
18 mai 2020 07h30 HE
|
Reliance Global Group, Inc.
LAKEWOOD, NJ, May 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Reliance Global Group, Inc. (OTCQB: RELI) ("RELI" or the "Company") today announced the appointment of David Lazar as an independent...